Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII)
- PMID: 1970724
- PMCID: PMC1131328
- DOI: 10.1042/bj2670557
Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII)
Abstract
Plasma Factor XIII is a zymogen (plasma protransglutaminase) with the tetrametric structure A2B2, whereas the cellular protransglutaminase, i.e. Factor XIII in the platelet and monocyte/macrophage, consists exclusively of A subunits (A2). It is generally accepted that at Ca2+ concentrations comparable with that in plasma the proteolytic removal of an N-terminal activation peptide is the prerequisite for the Ca2(+)-induced formation of a catalytically active configuration of subunit A. In this study it was demonstrated that at high concentrations NaCl or KCl induced a non-proteolytic activation of cellular (placental macrophage) but not plasma protransglutaminase. The activation depended on time and salt concentration, and Ca2+, in the range 0-20 mM, greatly enhanced the activation process. At 1.25 M-NaCl maximal activation occurred within 60 min in the presence of 2 mM-CaCl2, and even at physiological NaCl concentration a slow progressive activation could be observed in the presence of Ca2+. The specific activity of salt-activated Factor XIII was 1.5-2.0-fold higher than that obtained after thrombin activation. The non-proteolytic activation of cellular protransglutaminase was abolished by the addition of subunit B of plasma Factor XIII in stoichiometric amount, which suggests that (one of) the physiological function(s) of the B subunit in plasma Factor XIII is to prevent the slow spontaneous activation of A subunit that would occur in a plasmatic environment.
Similar articles
-
Platelet factor XIII becomes active without the release of activation peptide during platelet activation.Thromb Haemost. 1993 Mar 1;69(3):282-5. Thromb Haemost. 1993. PMID: 8097064
-
Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.Crit Rev Clin Lab Sci. 1996;33(5):357-421. doi: 10.3109/10408369609084691. Crit Rev Clin Lab Sci. 1996. PMID: 8922891 Review.
-
Identification of intracellular factor XIII in human monocytes and macrophages.J Clin Invest. 1985 Aug;76(2):528-34. doi: 10.1172/JCI112002. J Clin Invest. 1985. PMID: 2863285 Free PMC article.
-
b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII.Biochim Biophys Acta. 1988 Sep 8;966(3):328-35. doi: 10.1016/0304-4165(88)90082-7. Biochim Biophys Acta. 1988. PMID: 2901275
-
Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.Physiol Rev. 2011 Jul;91(3):931-72. doi: 10.1152/physrev.00016.2010. Physiol Rev. 2011. PMID: 21742792 Review.
Cited by
-
Transglutaminase Activities of Blood Coagulant Factor XIII Are Dependent on the Activation Pathways and on the Substrates.Thromb Haemost. 2023 Apr;123(4):380-392. doi: 10.1055/a-1993-4193. Epub 2022 Dec 6. Thromb Haemost. 2023. PMID: 36473493 Free PMC article.
-
Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes.Int J Mol Sci. 2019 Nov 27;20(23):5963. doi: 10.3390/ijms20235963. Int J Mol Sci. 2019. PMID: 31783511 Free PMC article.
-
Reversible activation of cellular factor XIII by calcium.J Biol Chem. 2011 Mar 18;286(11):9833-9. doi: 10.1074/jbc.M110.174128. Epub 2011 Jan 18. J Biol Chem. 2011. PMID: 21245142 Free PMC article.
-
Fbg αC 389-402 Enhances Factor XIII Cross-Linking in the Fibrinogen αC Region Via Electrostatic and Hydrophobic Interactions.Biochemistry. 2023 Jul 18;62(14):2170-2181. doi: 10.1021/acs.biochem.3c00066. Epub 2023 Jul 6. Biochemistry. 2023. PMID: 37410946 Free PMC article.
-
Factor XIII-A in Diseases: Role Beyond Blood Coagulation.Int J Mol Sci. 2021 Feb 1;22(3):1459. doi: 10.3390/ijms22031459. Int J Mol Sci. 2021. PMID: 33535700 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous